Neuroblastoma: Current Imaging and Therapeutics

Journal Title: Journal of Cancer and Tumor International - Year 2015, Vol 2, Issue 3

Abstract

Neuroblastoma is the most common solid abdominal tumor in children under the age of 2 years and accounts for approximately 15% of childhood mortality due to cancer. Its clinical behavior can vary from spontaneous regression to rapid fatal progression and anywhere in between (e.g. differentiation into benign tumors). Unfortunately, 50% of patients already have metastases at presentation. This marked clinical variability and often advanced presentation at time of diagnosis must be addressed with improved imaging and new treatments, particularly through focus on expanded drug development. Current treatment regimens (surgical resection, chemotherapy, and radiotherapy) have proven to be inadequate for treating advanced disease and frequently cause severe side effects that make them intolerable for many children. Promising new therapies include anti-adhesion therapy and immunotherapy, which uses antibodies to trigger a patient’s own immune system to destroy neuroblastoma cells. Of particular interest in the realm of anti-adhesion is attenuation of NF-κB over-activation. Increased NF-κB activity is thought to play a role in the development of tumor resistance to chemotherapeutic agents and radiation. Therefore, novel drugs to attenuate NF-kB activity could revolutionize treatment by increasing overall treatment effectiveness and allowing for reduced drug and radiation doses for dose-sensitive patients.

Authors and Affiliations

Xudong Huang, Ami K. Patel, Krupa K. Patel, Eva-Maria Ratai

Keywords

Related Articles

Level of Awareness on Breast Cancer and Practice of Breast Self-Examination among Market Women in Ido Community, Ido-Ekiti, Ekiti State, Nigeria

Aim: The study assessed the level of awareness on breast cancer and practice of breast self-examination among market women in Ido community, Ido-Ekiti, Ekiti State, Nigeria. Study Design: It made use of a descriptive res...

Potential Antineoplastic Structural Variations of Uracil Mustard (Uramustine) Retaining Cytotoxic Activity and Drug-likeness Suitable for Oral Administration

Aims: To present 12 new variants of uracil mustard having drug-like properties and cytotoxic functional group, by utilizing uracil mustard (uramustine) as a lead compound. Utilize rigorous substructure and similarity of...

Histo-Epidemiology of Kidney Cancer in Cameroon: About 110 Cases

Objectives: To describe the epidemiological and histopathological aspects of kidney cancer in Cameroon. Materials and Methods: This was a descriptive retrospective study on malignant tumors of the kidney examined in the...

Primary Synovial Sarcoma of the Prostate Gland: A Review of the Literature

Background: Primary synovial sarcoma of the prostate gland (PSSP) is rare and most clinicians would be unfamiliar with its biological behaviour. Aim: To review the literature on PSSP. Methods: Various internet data bases...

Myofibroblastoma of Axillary Soft Tissue in a Child

Aims: Myofibroblastoma (MFB) is an unusual benign mesenchymal tumour which has neoplastic cells showing a variable myofibroblastic differentiation at morphologic, immunohistochemical and ultrastructural levels. MFB is co...

Download PDF file
  • EP ID EP242956
  • DOI 10.9734/JCTI/2015/16165
  • Views 101
  • Downloads 0

How To Cite

Xudong Huang, Ami K. Patel, Krupa K. Patel, Eva-Maria Ratai (2015). Neuroblastoma: Current Imaging and Therapeutics. Journal of Cancer and Tumor International, 2(3), 89-109. https://europub.co.uk/articles/-A-242956